Bluestar diabetes

We weten dat leven met diabetes zwaar kan zijn. Daarom maken we zelfzorg voor diabetes makkelijker. BlueStar® biedt dagelijkse digitale coaching die uniek is voor jou; om u te helpen meer te weten te komen over uw toestand, betere gewoonten op te bouwen en uw beste leven te leiden.Onze diabetes-app is bekroond**, goedgekeurd door de FDA* en past gemakkelijk in uw dagelijks leven - terwijl u onderweg handige tips en advies krijgt. Het is gebruiksvriendelijk, probleemloos en veilig.Let op: BlueStar is alleen beschikbaar via uw zorgverzekering, zorgverzekeraar of werkgever.BlueStar kan het leven met diabetes gemakkelijker maken door:DIGITALE COACHING:Ontvang de juiste begeleiding op het juiste moment - alles in één gebruiksvriendelijke app.TOTALE GEZONDHEIDSAANPAK VAN DIABETES:Help betere gewoonten op te bouwen en te behouden door uw medicijnen, voeding, activiteit, apparaten en gezondheidsgegevens te koppelen.DE ONDERSTEUNING DIE U NODIG HEBT OM UW BLOEDGLUCOSE TE BEHEERSEN:Leer wat je nodig hebt - in je eigen tempo - met gebruiksvriendelijke tools en eenvoudig te volgen begeleiding in de app.DEEL JE VOORUITGANG:Vier uw successen en deel uw uitdagingen met uw arts en zorgteam - eenvoudig en snel.*BlueStar® Rx/OTC is een door de FDA goedgekeurd medisch hulpmiddel, bedoeld voor gebruik door zorgverleners en hun volwassen patiënten met diabetes type 1 of type 2. Ga voor volledige etiketteringsinformatie naar www.welldoc.com.**Door Tech Times uitgeroepen tot Beste Diabetes Apps voor Suikerbewuste Peeps 2021BlueStar® is Software as a Medical Device (SaMD) bedoeld voor gebruik door zorgverleners (HCP's) en hun patiënten - van 18 jaar en ouder - die diabetes type 1 of type 2 hebben. BlueStar is bedoeld om patiënten te helpen bij het beheersen van hun diabetes onder begeleiding van hun zorgverleners. BlueStar heeft twee versies – BlueStar en BlueStar Rx. BlueStar is niet bedoeld ter vervanging van de zorg die wordt verleend door een bevoegde zorgverlener. BlueStar mag niet worden

Its simplicity and basic features have merit. It's clear to read and understand, making it ideal for managing blood sugar levels, ideal for those who do not intend to radically alter what they eat and may rely on insulin.‍The Hedia - Personal Diabetes app provides:‍Exercise trackingDiet TrackingInsulin dose calculationProvides notifications when blood glucose should be measured.‍The application then provides insulin dose recommendations for those who require it. Whether this application is for you, really depends on your needs. It may well suit older diabetes sufferers. Note that the application is not available in many countries, and is rarely seen on Google’s play store search results. If you search for it in the store, it may not be found in some countries in the EU, despite the developer being located in Denmark.‍6. BlueStar Android App on the PlaystoreSource: Android Play Store‍The BlueStar Diabetes application claims that it was the world’s first prescription-only smartphone application, released way back in 2014. Consequently, it is only available in the US through employers, health plans, and health care providers. Outside of the app, there is a distinct lack of information about the application, and cannot be found on the Playstore in many locations.‍Since 2013 WellDoc has had FDA approval for type 1 diabetes, albeit through a different version of the app, which integrates with the Dexcom continuous glucose monitors. The application itself is provided to the patient for free of charge on a prescription basis and will be reimbursed in a similar fashion to prescription

United States of both conditions combined exceeds $370.6 billion. In 2022, the annual burden per person averaged $12,022 for diagnosed diabetes and $955 for prediabetes [3]. This includes $413 billion in excess medical costs (e.g., physician's office and hospital visits, prescription drug costs, costly health conditions) and $106 billion in reduced productivity [3]. Spending on diabetes is expected to triple in the next 25 years [11].In addition to monetary costs, chronic complications of diabetes significantly diminish quality of life for the individual and account for more new cases of blindness, end-stage renal disease, and lower limb amputation than any other medical diagnosis [12]. The incidence of diabetes has been steadily growing. Estimates for 2021 indicate that 38.4 million people in the United States have diabetes [3]. If obesity rates remain stable, the number of Americans with diabetes will double in the next 25 years [11]. Nearly 23% of people with diabetes do not know they have the disease [3]. According to a panel of clinical endocrinology experts, "As the prevalence of and progression to diabetes continue to increase, diabetes-related morbidity and mortality have emerged as major public health issues" [6].Reducing the incidence of diabetes or delaying its onset provides an enormous opportunity to arrest the growth and development of this major health problem. The Diabetes Prevention Program (DPP) showed that when overweight people with prediabetes made healthy lifestyle changes, they could significantly reduce their risk for developing type 2 diabetes [2]. Healthcare professionals play an essential role in helping patients

Resistance continues, blood sugar levels gradually increase, leading to prediabetes, a condition where blood sugar levels are elevated but not yet high enough for a diabetes diagnosis. Without intervention, prediabetes often progresses to type 2 diabetes. Keep in mind that insulin resistance is specific to type 2 diabetes and does not cause type 1 diabetes. Type 1 diabetes results from an autoimmune reaction where your body’s immune system mistakenly attacks insulin-producing cells in your pancreas, leading to little or no insulin production. Patients with type 1 diabetes do not have insulin resistance; rather, they need external insulin because their bodies cannot produce it naturally. The progression from insulin resistance to type 2 diabetes can often be slowed or even reversed with lifestyle changes. Some research shows that losing as little as 5-10% of body weight, eating a balanced diet, and incorporating regular exercise can improve your body’s response to insulin, helping to prevent or delay the development of type 2 diabetes. Preventing and Managing Insulin Resistance and Diabetes While there's no cure for diabetes, lifestyle modifications can help prevent and manage both insulin resistance and diabetes: Healthy Diet: A balanced diet rich in fruits, vegetables, whole grains, and lean protein can help regulate blood sugar levels. Regular Physical Activity: Regular exercise can improve insulin sensitivity and help control blood sugar levels. Weight Management: Maintaining a healthy weight can reduce the risk of insulin resistance and diabetes. Medication: In some cases, medication may be necessary to manage blood sugar levels.

Of future cardiovascular events.Works Cited2. Knowler WC, Barrett-Conner E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. 4. Andes LJ, Cheng YJ, Rolka DB. Prevalence of prediabetes among adolescents and young adults in the United States, 2005–2016. JAMA Pediatr. 2020;174(2):e194498. 5. Tabäk AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for developing diabetes. Lancet. 2012;379(9833):2279-2290. 6. American College of Endocrinology, American Association of Clinical Endocrinologists. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of clinical endocrinologists. Endocr Prac. 2008;14(7):933-946. current 7. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF. Regression from prediabetes to normal glucose regulation in the Diabetes Prevention Program. Diabetes Care. 2009;32(9):1583-1588. 8. Perreault L, Temprosa M, Mather KJ, et al. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. Diabetes Care. 2014;37(9):2622-2631. 9. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention program. Diabet Med. 2007;24(2):137-144. 10. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14(1):23-29. 11. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32(12):2225-2229. 13. American Diabetes Association. Standards of medical care